CAV1 and cancer: A clinicopathological study demonstrated that patients with Cav-1+ CAFs had significantly higher rates of vascular and pleural invasion than those with Cav-1− CAFs, and a similar correlation was exhibited by Cav-1+ cancer cells [31].